HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

Highlights Hansoh Pharmaceutical Group Company Limited

Equities

3692

KYG549581067

Market Closed - Hong Kong S.E. Other stock markets 01:38:04 19/06/2024 pm IST			5-day change	1st Jan Change
17.32 ^HKD	+0.48%		-1.81%	+9.90%

14/06	Hansoh Pharmaceutical Slashes Conversion Price of Convertible Bonds	MT
29/04	Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Hansoh Pharmaceutical Slashes Conversion Price of Convertible Bonds	14/06	MT
Hansoh Pharmaceutical’s 2023 Profit Up 27%	30/04	MT
Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug	03/04	MT
Hansoh Pharmaceutical Group Company Limited, Jiangsu Hansoh Pharmaceutical Group Company Limited and Shanghai Hansoh Biomedical Technology Company Limited Receives Grant of A Clinical Trial Notice Issued by the National Medical Products Administration of the People's Republic of China to Be Used for the Treatment of Advanced Non-Small Cell Lung Cancer	03/04	CI
Hansoh Pharmaceutical Group Company Limited Recommends Final Dividend, Payable on July 17, 2024	26/03	CI
Hansoh Pharmaceutical Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	26/03	CI
Hansoh Pharmaceutical Gets Nod to Trial Nephropathy Treatment Capsules	08/02	MT
Hansoh Pharmaceutical Buys Back 3 Million Shares	31/01	MT
Hansoh Secures Chinese Nod For Clinical Trial Of Anti-Diabetes Drug	23/01	MT
Hansoh Pharmaceutical Units Gets Clinical Trial Notice in China for Schizophrenia Treatment	17/01	MT
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of HS-10509 Tablets	17/01	CI
Hansoh Pharmaceutical’s Trustee Buys Back Shares	02/01	MT
GSK plc Enters Exclusive License Agreement with Hansoh for HS-20093	20/12	CI
GSK looks for deals in China as rebuilds relationship	17/12	AN
Hansoh Pharma's Three Drugs Added to China’s National Reimbursement Drug List	14/12	MT
China OKs Clinical Trial for Hansoh Pharmaceutical Units' Hypertrophic Cardiomyopathy Treatment	13/11	MT
Shanghai Hansoh Biomedical Technology Company Limited and Jiangsu Hansoh Pharmaceutical Group Company Limited Receives Clinical Trial Notice	10/11	CI
China Grants Drug Registration Approval for Hansoh Pharma Unit's Skin Infection Treatment	03/11	MT
Hansoh Pharmaceutical Gets Nod to Test HS-20106 Injections	20/23/20	MT
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of Hs-20106 Injections	19/23/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hansoh Pharmaceutical Group Company Limited

Equities

3692

KYG549581067

Highlights

Filters